{"id":538538,"date":"2021-09-15T08:33:17","date_gmt":"2021-09-15T12:33:17","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/simulations-plus-releases-admet-predictor-x-3\/"},"modified":"2021-09-15T08:33:17","modified_gmt":"2021-09-15T12:33:17","slug":"simulations-plus-releases-admet-predictor-x-3","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/simulations-plus-releases-admet-predictor-x-3\/","title":{"rendered":"Simulations Plus Releases ADMET Predictor\u00ae (X.3)"},"content":{"rendered":"<p>        <!--.bwalignc { text-align: center; list-style-position: inside }\n.bwlistdisc { list-style-type: disc }\n.bwuline { text-decoration: underline }body {font:normal small Arial,Helvetica,sans-serif;color:#000;background-color:#fff;padding:24px;margin:0;} a img {border:0;} h3 {font-size:medium;color:#000;margin:0 0 1em 0; text-align:center;}-->  <\/p>\n<p class=\"bwalignc\"><b>Simulations Plus Releases ADMET Predictor<sup>\u00ae<\/sup> (X.3)<\/b><\/p>\n<p class=\"bwalignc\"><b><i>New capabilities further solidify ADMET Predictor\u2019s position as the preferred platform for ADMET modeling and AI-driven compound optimization<\/i><\/b><\/p>\n<p>LANCASTER, Calif.&#8211;(<a href=\"http:\/\/www.businesswire.com\">BUSINESS WIRE<\/a>)&#8211;<a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.simulations-plus.com%2F%3Futm_source%3DIssuerDirect%26utm_medium%3Dpressrelease%26utm_campaign%3Dapx3release&amp;esheet=52492039&amp;newsitemid=20210915005276&amp;lan=en-US&amp;anchor=Simulations+Plus%2C+Inc.&amp;index=1&amp;md5=ebeac84db65254f637df23ed359ce967\">Simulations Plus, Inc.<\/a> (Nasdaq: SLP), a leading provider of modeling and simulation solutions for the pharmaceutical, biotechnology, chemical, and consumer goods industries, today announced that it has released version 10.3 of its flagship machine learning modeling platform, <a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.simulations-plus.com%2Fsoftware%2Fadmetpredictor%2F%3Futm_source%3DIssuerDirect%26utm_medium%3Dpressrelease%26utm_campaign%3Dapx3release&amp;esheet=52492039&amp;newsitemid=20210915005276&amp;lan=en-US&amp;anchor=ADMET+Predictor%26%23174%3B&amp;index=2&amp;md5=ca5ab1351a07ca72b93d1cb96fb6c325\">ADMET Predictor<sup>\u00ae<\/sup><\/a>. The new release will be marketed as APX.3.\n<\/p>\n<p>\nKey enhancements in APX.3 include:\n<\/p>\n<ul class=\"bwlistdisc\">\n<li>\nNew capabilities in the Artificial Intelligence-driven Drug Design (<a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.simulations-plus.com%2Fsoftware%2Fadmetpredictor%2Fai-driven-drug-design-aidd%2F%3Futm_source%3DIssuerDirect%26utm_medium%3Dpressrelease%26utm_campaign%3Dapx3release&amp;esheet=52492039&amp;newsitemid=20210915005276&amp;lan=en-US&amp;anchor=AIDD&amp;index=3&amp;md5=c8f4f2e12687f700f43611a9bd3ac6a2\">AIDD<\/a>) Module to incorporate calculations from any third-party program for use in compound optimization expanding client\u2019s existing toolbox\n<\/li>\n<li>\nMajor update to CYP metabolism models with a new knowledgebase that significantly expands the addressable chemical coverage space\n<\/li>\n<li>\nAccess to <a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.simulations-plus.com%2Fsoftware%2Fadmetpredictor%2Fmedchem-studio%2F%3Futm_source%3DIssuerDirect%26utm_medium%3Dpressrelease%26utm_campaign%3Dapx3release&amp;esheet=52492039&amp;newsitemid=20210915005276&amp;lan=en-US&amp;anchor=MedChem+Studio%26%238482%3B&amp;index=4&amp;md5=2b326139ed59be5a63d8165dab7d48af\">MedChem Studio\u2122<\/a> extended to all users to provide high-quality data visualization, compound clustering, and high throughput screening analysis functionality to enhance data analytics capabilities for general use\n<\/li>\n<li>\nNew REST API for deployment via Web services\n<\/li>\n<\/ul>\n<p><a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.simulations-plus.com%2Fperson%2Fdavid-miller%2F%3Futm_source%3DIssuerDirect%26utm_medium%3Dpressrelease%26utm_campaign%3Dapx3release&amp;esheet=52492039&amp;newsitemid=20210915005276&amp;lan=en-US&amp;anchor=Dr.+David+Miller&amp;index=5&amp;md5=4f8cc7528cc5de195003bcf2615ecc28\">Dr. David Miller<\/a>, vice president of ADMET Cheminformatics, said: \u201cAPX.3 enhances the already industry-leading capabilities within the ADMET Predictor AIDD Module and establishes the program as the premier environment for AI-driven drug discovery. Leveraging the outputs from third-party programs, such as those from 3D molecular docking applications or advanced statistical packages such as R, complements the novel physiologically based pharmacokinetic (PBPK) modeling methods embedded within the module and unlocks the completely unique ability to optimize molecules based on combinations of activity and systemic exposure. This differentiates ADMET Predictor from other companies and opens new doors for the AI-driven drug design community.\u201d\n<\/p>\n<p><a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.simulations-plus.com%2Fperson%2Feric-jamois%2F%3Futm_source%3DIssuerDirect%26utm_medium%3Dpressrelease%26utm_campaign%3Dapx3release&amp;esheet=52492039&amp;newsitemid=20210915005276&amp;lan=en-US&amp;anchor=Dr.+Eric+Jamois&amp;index=6&amp;md5=2800dad19fe4d2c11269add48c31d6cc\">Dr. Eric Jamois<\/a>, director for key accounts and strategic alliances, added: \u201cMajor themes for this release include \u2018knowledge expansion\u2019 and \u2018easy access.\u2019 By providing extended data analysis capabilities to our users through the now free MedChem Studio Module and developing the REST API deployment option, we expect to grow our user base across the computational chemistry, medicinal chemistry, and DMPK departments. Also, the expansion of our metabolism databases means we now cover a wider chemical space with our machine learning predictions for CYP enzymes, which we expect will help solidify the position of ADMET Predictor as the preferred ADMET modeling platform and maintain its double-digit revenue growth course as we head into our 2022 fiscal year.\u201d\n<\/p>\n<p>\nWatch this short <a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fyoutu.be%2FihMw-3Gv5E8&amp;esheet=52492039&amp;newsitemid=20210915005276&amp;lan=en-US&amp;anchor=video&amp;index=7&amp;md5=488a42db91de03fae49ae8bed6a30cdb\">video<\/a> to learn more on the advancements of APX.3.\n<\/p>\n<p><b>About Simulations Plus, Inc.<\/b><\/p>\n<p>\nServing clients worldwide for 25 years, Simulations Plus, Inc., is a leading provider of modeling and simulation software and consulting services supporting drug discovery, development research, and regulatory submissions. With our subsidiaries Cognigen, DILIsym Services, and Lixoft, we offer solutions that bridge machine learning, physiologically based pharmacokinetics, quantitative systems pharmacology\/toxicology, and population PK\/PD modeling approaches. Our technology is licensed and applied by major pharmaceutical, biotechnology, chemical, consumer goods companies, and regulatory agencies worldwide. For more information, visit our website at <a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.simulations-plus.com%2F%3Futm_source%3DIssuerDirect%26utm_medium%3Dpressrelease%26utm_campaign%3Dapx3release&amp;esheet=52492039&amp;newsitemid=20210915005276&amp;lan=en-US&amp;anchor=www.simulations-plus.com&amp;index=8&amp;md5=f2d5a41468460633840ed847bf01287b\">www.simulations-plus.com<\/a>. Follow us on <a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Ftwitter.com%2FSimulationsPlus&amp;esheet=52492039&amp;newsitemid=20210915005276&amp;lan=en-US&amp;anchor=Twitter&amp;index=9&amp;md5=db2bb7d2e7a9159d86c88a68af3a342e\">Twitter<\/a> | Read our <a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.simulations-plus.com%2Fassets%2FSLP_2020-ESG-Report-2.pdf&amp;esheet=52492039&amp;newsitemid=20210915005276&amp;lan=en-US&amp;anchor=Environmental%2C+Social%2C+and+Governance+%28ESG%29+Report&amp;index=10&amp;md5=9cc814d701caa490832c390b535fbea8\">Environmental, Social, and Governance (ESG) Report<\/a>.\n<\/p>\n<p><b>Safe Harbor Statement Under the Private Securities Litigation Reform Act of 1995<\/b> \u2013 With the exception of historical information, the matters discussed in this press release are forward-looking statements that involve a number of risks and uncertainties. Words like \u201cbelieve,\u201d \u201cexpect\u201d and \u201canticipate\u201d mean that these are our best estimates as of this writing, but that there can be no assurances that expected or anticipated results or events will actually take place, so our actual future results could differ significantly from those statements. Factors that could cause or contribute to such differences include, but are not limited to: our ability to maintain our competitive advantages, acceptance of new software and improved versions of our existing software by our customers, the general economics of the pharmaceutical industry, our ability to finance growth, our ability to continue to attract and retain highly qualified technical staff, our ability to identify and close acquisitions on terms favorable to the Company, and a sustainable market. Further information on our risk factors is contained in our quarterly and annual reports and filed with the U.S. Securities and Exchange Commission.\n<\/p>\n<p><img decoding=\"async\" alt=\"\" src=\"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20210915005276r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\" style=\"width:0;height:0\" \/><span class=\"bwct31415\" \/><\/p>\n<p id=\"mmgallerylink\"><span id=\"mmgallerylink-phrase\">View source version on businesswire.com: <\/span><span id=\"mmgallerylink-link\"><a href=\"https:\/\/www.businesswire.com\/news\/home\/20210915005276\/en\/\" rel=\"nofollow\">https:\/\/www.businesswire.com\/news\/home\/20210915005276\/en\/<\/a><\/span><\/p>\n<p><span class=\"bwuline\">Simulations Plus Investor Relations<br \/>\n<\/span><br \/>Ms. Renee Bouche<br \/>\n<br \/>661-723-7723<br \/>\n<br \/><a rel=\"nofollow\" href=\"mailto:renee@simulations-plus.com\">renee@simulations-plus.com<\/a><\/p>\n<p><span class=\"bwuline\">Hayden IR<br \/>\n<\/span><br \/>Mr. Brian Siegel<br \/>\n<br \/>346-396-8696<br \/>\n<br \/><a rel=\"nofollow\" href=\"mailto:brian@haydenir.com\">brian@haydenir.com<\/a><\/p>\n<p><b>KEYWORDS:<\/b> United States North America California<\/p>\n<p><b>INDUSTRY KEYWORDS:<\/b> Consulting Biotechnology Technology Manufacturing Professional Services Health Pharmaceutical Research Software Science Chemicals\/Plastics<\/p>\n<p><b>MEDIA:<\/b><\/p>\n<table cellpadding=\"3\" cellspacing=\"3\">\n<tr>\n<td><font face=\"Arial\" size=\"2\"><b>Logo<\/b><\/font><\/td>\n<\/tr>\n<tr>\n<td><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20210915005276\/en\/1144961\/3\/25thSLPLogoStacked-Light.jpg\" alt=\"Logo\" \/><\/td>\n<\/tr>\n<tr>\n<td><font face=\"Arial\" size=\"2\"><\/font><\/td>\n<\/tr>\n<\/table>\n","protected":false},"excerpt":{"rendered":"<p>Simulations Plus Releases ADMET Predictor\u00ae (X.3) New capabilities further solidify ADMET Predictor\u2019s position as the preferred platform for ADMET modeling and AI-driven compound optimization LANCASTER, Calif.&#8211;(BUSINESS WIRE)&#8211;Simulations Plus, Inc. (Nasdaq: SLP), a leading provider of modeling and simulation solutions for the pharmaceutical, biotechnology, chemical, and consumer goods industries, today announced that it has released version 10.3 of its flagship machine learning modeling platform, ADMET Predictor\u00ae. The new release will be marketed as APX.3. Key enhancements in APX.3 include: New capabilities in the Artificial Intelligence-driven Drug Design (AIDD) Module to incorporate calculations from any third-party program for use in compound optimization expanding client\u2019s existing toolbox Major update to CYP metabolism models with a new knowledgebase that significantly expands the addressable chemical &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/simulations-plus-releases-admet-predictor-x-3\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Simulations Plus Releases ADMET Predictor\u00ae (X.3)&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-538538","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.8 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Simulations Plus Releases ADMET Predictor\u00ae (X.3) - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/simulations-plus-releases-admet-predictor-x-3\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Simulations Plus Releases ADMET Predictor\u00ae (X.3) - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"Simulations Plus Releases ADMET Predictor\u00ae (X.3) New capabilities further solidify ADMET Predictor\u2019s position as the preferred platform for ADMET modeling and AI-driven compound optimization LANCASTER, Calif.&#8211;(BUSINESS WIRE)&#8211;Simulations Plus, Inc. (Nasdaq: SLP), a leading provider of modeling and simulation solutions for the pharmaceutical, biotechnology, chemical, and consumer goods industries, today announced that it has released version 10.3 of its flagship machine learning modeling platform, ADMET Predictor\u00ae. The new release will be marketed as APX.3. Key enhancements in APX.3 include: New capabilities in the Artificial Intelligence-driven Drug Design (AIDD) Module to incorporate calculations from any third-party program for use in compound optimization expanding client\u2019s existing toolbox Major update to CYP metabolism models with a new knowledgebase that significantly expands the addressable chemical &hellip; Continue reading &quot;Simulations Plus Releases ADMET Predictor\u00ae (X.3)&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/simulations-plus-releases-admet-predictor-x-3\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2021-09-15T12:33:17+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20210915005276r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/simulations-plus-releases-admet-predictor-x-3\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/simulations-plus-releases-admet-predictor-x-3\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Simulations Plus Releases ADMET Predictor\u00ae (X.3)\",\"datePublished\":\"2021-09-15T12:33:17+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/simulations-plus-releases-admet-predictor-x-3\\\/\"},\"wordCount\":737,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/simulations-plus-releases-admet-predictor-x-3\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20210915005276r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/simulations-plus-releases-admet-predictor-x-3\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/simulations-plus-releases-admet-predictor-x-3\\\/\",\"name\":\"Simulations Plus Releases ADMET Predictor\u00ae (X.3) - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/simulations-plus-releases-admet-predictor-x-3\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/simulations-plus-releases-admet-predictor-x-3\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20210915005276r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\",\"datePublished\":\"2021-09-15T12:33:17+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/simulations-plus-releases-admet-predictor-x-3\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/simulations-plus-releases-admet-predictor-x-3\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/simulations-plus-releases-admet-predictor-x-3\\\/#primaryimage\",\"url\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20210915005276r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\",\"contentUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20210915005276r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/simulations-plus-releases-admet-predictor-x-3\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Simulations Plus Releases ADMET Predictor\u00ae (X.3)\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Simulations Plus Releases ADMET Predictor\u00ae (X.3) - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/simulations-plus-releases-admet-predictor-x-3\/","og_locale":"en_US","og_type":"article","og_title":"Simulations Plus Releases ADMET Predictor\u00ae (X.3) - Market Newsdesk","og_description":"Simulations Plus Releases ADMET Predictor\u00ae (X.3) New capabilities further solidify ADMET Predictor\u2019s position as the preferred platform for ADMET modeling and AI-driven compound optimization LANCASTER, Calif.&#8211;(BUSINESS WIRE)&#8211;Simulations Plus, Inc. (Nasdaq: SLP), a leading provider of modeling and simulation solutions for the pharmaceutical, biotechnology, chemical, and consumer goods industries, today announced that it has released version 10.3 of its flagship machine learning modeling platform, ADMET Predictor\u00ae. The new release will be marketed as APX.3. Key enhancements in APX.3 include: New capabilities in the Artificial Intelligence-driven Drug Design (AIDD) Module to incorporate calculations from any third-party program for use in compound optimization expanding client\u2019s existing toolbox Major update to CYP metabolism models with a new knowledgebase that significantly expands the addressable chemical &hellip; Continue reading \"Simulations Plus Releases ADMET Predictor\u00ae (X.3)\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/simulations-plus-releases-admet-predictor-x-3\/","og_site_name":"Market Newsdesk","article_published_time":"2021-09-15T12:33:17+00:00","og_image":[{"url":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20210915005276r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"4 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/simulations-plus-releases-admet-predictor-x-3\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/simulations-plus-releases-admet-predictor-x-3\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Simulations Plus Releases ADMET Predictor\u00ae (X.3)","datePublished":"2021-09-15T12:33:17+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/simulations-plus-releases-admet-predictor-x-3\/"},"wordCount":737,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/simulations-plus-releases-admet-predictor-x-3\/#primaryimage"},"thumbnailUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20210915005276r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/simulations-plus-releases-admet-predictor-x-3\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/simulations-plus-releases-admet-predictor-x-3\/","name":"Simulations Plus Releases ADMET Predictor\u00ae (X.3) - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/simulations-plus-releases-admet-predictor-x-3\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/simulations-plus-releases-admet-predictor-x-3\/#primaryimage"},"thumbnailUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20210915005276r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","datePublished":"2021-09-15T12:33:17+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/simulations-plus-releases-admet-predictor-x-3\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/simulations-plus-releases-admet-predictor-x-3\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/simulations-plus-releases-admet-predictor-x-3\/#primaryimage","url":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20210915005276r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","contentUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20210915005276r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en"},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/simulations-plus-releases-admet-predictor-x-3\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Simulations Plus Releases ADMET Predictor\u00ae (X.3)"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/538538","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=538538"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/538538\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=538538"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=538538"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=538538"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}